LAB+ Venture Builder, an initiative promoted by the Institut Pasteur de Montevideo with the financial and know-how contribution of the investment banking firm FICUS Advisory, is now launching an international call to bring together in 2023 research & innovator group leaders willing to create Startups with a remarkable goal in life sciences and in the promotion of “One Health”.
Typically, funding will support disruptive research aiming to discover and further develop relevant life sciences-derived products or services with the potential to pursuit intellectual property protection and commercialization of the invention. We focus on revolutionary projects playing at the intersection of medicine, biology & technology to improve the well-being of humans, animals & the environment. Potential focus of proposals includes —but are not limited to— Healthcare, Medtech, Drug discovery and Pharma, Diagnostics & Biotech, Agtech & Foodtech with potential for global rollout and impact.
The awards are for scientists/entrepreneurs having an extensive training in research (PhDs, MDs, Chemists, Engineer) who have a revolutionary idea, an exciting and original research & development project, with commercial or high socio-economic potential. Actual or near future intellectual property is mandatory.
The following proposal’s features will be considered for the evaluation:
- Highly innovative technology with solid scientific foundations.
- Well-defined, feasible and achievable objectives for the defined project period.
- Clear definition of the market problem addressed by the research and analysis of the market potential.
- Understanding of the current state of the art in intellectual property.
- Motivated teams with outstanding scientific careers and a great willingness to work as a multidisciplinary team and in an enjoyable way
LAB+ will strongly encourage, support and value research collaboration with our already established groups as a mechanism to potentiate innovative research.
Awards for each startup include funding, a top-notch science ecosystem and deep international business and entrepreneurial experience on how to build, operate, fund and grow a world-class company. Teams selected will go through a progress & de-risking model, stage-gated, evolutionary and networked. The funding amount and the developmental stage of the project in agreement with the de-risking model will be assign in accordance to the proposal evaluation made by the scientific, financial and investment structure of LAB+ (as a general indicator, seed money for mature projects will be up to US$ 750 K for a 2 years’ period). Laboratory facility (30 mts2) and open access to the IP Montevideo core facilities will be possible in a limited number of projects where our core infrastructure may be of paramount importance for Startup development.
The selection of applications includes a four-step process: click here
1) Screening and Selection
2) LAB+ Staff analysis and co-working
3) Due Diligence
4) Investment Committee.
To apply:
Candidates must complete the following on-line form with non-confidential information:
Deadline:
December 15, 2022
The Institut Pasteur de Montevideo is an institution committed to the promotion of an organisational culture of gender equality. The Institute adheres to the national Law 17.817 on combating racism, xenophobia and all other forms of discrimination and Law Nº 18.104 on equal rights and opportunities between men and women.